Free Trial
OTCMKTS:NHNKY

Nihon Kohden 2/5/2025 Earnings Report

Nihon Kohden logo
$13.00 +2.19 (+20.26%)
As of 05/28/2025 03:31 PM Eastern

Nihon Kohden EPS Results

Actual EPS
$0.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nihon Kohden Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Nihon Kohden Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Nihon Kohden's next earnings date is estimated for Thursday, July 31, 2025, based on past reporting schedules.

Conference Call Resources

Nihon Kohden Earnings Headlines

Nihon Kohden FY Net Y14.10B Vs Net Y17.03B
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.
See More Nihon Kohden Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nihon Kohden? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nihon Kohden and other key companies, straight to your email.

About Nihon Kohden

Nihon Kohden (OTCMKTS:NHNKY) engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.

View Nihon Kohden Profile

More Earnings Resources from MarketBeat